Mishima, Japan

Kohki Tsukamoto

This inventor holds 2 USPTO granted patents. Top assignee: Ono Pharmaceutical Co., Ltd.. Active years: 2009-2012.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Kohki Tsukamoto. Retrieved from https://idiyas.com/inventor/kohki-tsukamoto

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 13.0

ph-index = 1


Company Filing History:


Years Active: 2009-2012

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Kohki Tsukamoto: Innovator in Carboxylic Acid Compounds

Introduction: Kohki Tsukamoto, an inventive mind based in Mishima-gun, Japan, has made significant strides in the field of medicinal chemistry. With a total of two patents to his name, his work represents a promising advance in therapeutic compositions.

Latest Patents: Tsukamoto's latest patents focus on carboxylic acid compounds and their medicinal applications. The first patent details a compound represented by a specific formula, highlighting the active ingredient's potential in creating effective medicinal compositions. The second patent further explores similar compounds and their applications in medicine, underlining the innovative nature of his research.

Career Highlights: Currently employed by Ono Pharmaceutical Co., Ltd., Tsukamoto has demonstrated a commitment to advancing pharmacological research. His work contributes significantly to the development of new therapeutic options that may improve patient outcomes.

Collaborations: Throughout his career, Kohki Tsukamoto has collaborated with notable colleagues, including Atsushi Naganawa and Maki Iwahashi. These partnerships have fostered an environment of shared knowledge and innovation, helping to propel research initiatives forward.

Conclusion: Kohki Tsukamoto stands out as a dedicated inventor in the pharmaceutical field. His contributions through patents on carboxylic acid compounds exhibit not only his expertise but also his commitment to enhancing medicinal therapies. As he continues his work at Ono Pharmaceutical Co., Ltd., the potential for future innovations remains promising.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…